Overall, these data led us to hypothesize that miR-590-5p may act as a tumor suppressor in NSCLC via the STAT3 pathway, and could be a useful biomarker for the diagnosis/prognosis of NSCLC [58]. Here, STAT3 is linked to non-small cell lung carcinoma.